HDL particle number and size as predictors of cardiovascular disease

Area of Science:

• Cardiovascular Medicine
• Lipid Metabolism
• Preventive Cardiology

Background:

• Circulating high-density lipoprotein (HDL) particles, rather than HDL-cholesterol (HDL-C) levels, are increasingly recognized for their predictive power in cardiovascular disease (CVD).
• Assessing HDL particle concentrations and profiles offers potential for improved cardiovascular risk assessment and evaluation of targeted therapies.

Purpose of the Study:

• To explore the clinical utility of measuring HDL particle numbers and profiles for cardiovascular risk assessment.
• To compare the predictive value of HDL particle concentrations versus HDL-C for cardiovascular disease.
• To investigate the relevance of HDL subpopulations and particle size in cardiovascular risk.

Main Methods:

• Analysis of circulating HDL particle concentrations and profiles.
• Epidemiological data review correlating HDL parameters with cardiovascular disease.
• Comparison of predictive accuracy between HDL particle number and HDL-C levels.

Main Results:

• Reduced concentrations of circulating HDL particles are superior to HDL-C as CVD predictors.
• A negative relationship exists between the number of large HDL particles and cardiovascular disease.
• Reduced mean HDL size is also associated with increased cardiovascular disease risk.

Conclusions:

• HDL particle number may be a more relevant therapeutic target than HDL-C for managing cardiovascular risk.
• In-depth analysis of HDL particle profiles can enhance cardiovascular risk evaluation.
• The predictive value of HDL subpopulations warrants further clinical investigation.